Last updated on February 2018

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy


Brief description of study

A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by maintenance therapy with DFMO in subjects with newly diagnosed high risk neuroblastoma.

Clinical Study Identifier: NCT02559778

Contact Investigators or Research Sites near you

Start Over

Jawhar Rawwas, MD

Children's Hospital and Clinics on Minnesota
Minneapolis, MN United States
1.24miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.